Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Craigbadon Aug 12, 2016 12:19pm
208 Views
Post# 25136062

RE:Some CXR math, 2nd half Ebidta of $250..

RE:Some CXR math, 2nd half Ebidta of $250.. Given how much the debt to ebitda guidance (which was already sky high) has risen, if Donnatal gets pulled it will almost become uninvestable. Pressure from competition, any investigations or fines in the Uk could easily drive this to single digits at any moment. Might be a tradeable bounce somewhere, but it will be scary for anyone to hold this in a portfolio for clients or in their own account unless its fun money they won't miss if it goes to zero. Jmho.

CookieMonster wrote: If you annualize that, gets you $500 mln.  TD uses 6.5x ebitda in their piece recently. That gets you $3,250 mln.  Subtract $3,300 mln. In debt, gets you ZERO.  Or use midpoint guidance of $525 mln. X 7 = $3,675.  Subtract debt of $3,300 = $375 mln. Equity value.  That is $7 U.S. Per share

<< Previous
Bullboard Posts
Next >>